PET心肌血流储备的时间变化:对心血管结局的意义
该研究回顾性分析2016至2022年耶鲁纽黑文医院474例无心脏移植史、因评估冠心病行系列PET心肌灌注显像(共948次检查)的患者,按心肌血流储备(MFR)轨迹分组,分析长期主要不良心血管事件(MACE,定义为死亡或心肌梗死)。中位随访17个月MACE发生率为12%(51例事件),多变量分析中低-低和低-高组MACE较高;包含系列MFR和灌注的模型在似然比和C统计量上优于仅含传统临床危险因素的基线模型(从0.74到0.80,P=0.04)。
要点
- 两次PET检查中位间隔776天,MFR相似(2.1 vs 2.1,P=0.75),但静息血流(1 vs 0.9,P<0.01)和负荷血流(2.1 vs 1.8,P<0.01)在第二次PET均降低。
- 两次检查间行血运重建的患者(62例)MFR升高(1.6 vs 1.7,P=0.04)。
- 中位随访17个月MACE发生率12%(51例事件),多变量分析中低-低和低-高组MACE较高。
核心结论
- 研究提示,系列评估MFR和灌注可能改善超越传统临床危险因素的风险分层。
研究设计与样本
- 回顾性分析474例无心脏移植史、因评估冠心病行系列PET心肌灌注显像(共948次检查)的患者,检查时间为2016年至2022年,地点为耶鲁纽黑文医院。
主要发现
- 两次检查中位间隔776天(IQR:497-1058),第一次和第二次PET最常见指征分别为胸痛和呼吸困难。
- MFR在系列检查中相似(2.1 [1.7, 2.6] vs 2.1 [1.7, 2.5],P=0.75),但静息血流(1 [0.8, 1.3] vs 0.9 [0.7, 1],P<0.01)和负荷血流(2.1 [1.6, 2.8] vs 1.8 [1.4, 2.2],P<0.01)在第二次PET均降低。
- 两次检查间行血运重建的患者(62例)MFR升高(1.6 [1.3, 2.0] vs 1.7 [1.2, 2.2],P=0.04)。
- 中位随访17 [8,28]个月期间,MACE发生率为12%(51例事件),多变量分析中低-低和低-高组MACE较高。
- 包含系列MFR和灌注的模型在似然比和C统计量上优于包含传统临床危险因素的基线模型(从0.74到0.80,P=0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The usefulness of serial measurements of myocardial flow reserve (MFR) has received limited study outside of transplant vasculopathy. We describe the trends of myocardial blood flow and perfusion over time in patients undergoing positron emission tomography (PET) myocardial perfusion imaging (MPI) for the evaluation of coronary artery disease, and their association with cardiovascular outcomes. METHODS: We retrospectively analyzed data from 474 patients without a history of heart transplant who underwent serial PET MPI (N = 948 studies) for the evaluation of coronary artery disease at Yale New Haven Hospital between 2016 and 2022. Patients were categorized according to MFR trajectory (low to low, low to high, high to low, high to high). Long-term major adverse cardiovascular events (MACE), defined as death or myocardial infarction, were analyzed with the Kaplan-Meier method and Cox regression. Log-likelihood, C-statistic and net reclassification were used to assess model performance. RESULTS: The median interval time between tests was 776 days (IQR: 497-1058). The most common indications for the first and second PET were chest pain and dyspnea. MFR was similar in serial exams (2.1 [1.7, 2.6] vs 2.1 [1.7, 2.5], P = .75), but rest (1 [.8, 1.3] vs .9 [.7, 1] P < .01) and stress flows (2.1 [1.6, 2.8] vs 1.8 [1.4, 2.2], P < .01) were both reduced on the second PET. MFR increased in patients with revascularization between tests (N = 62 patients) (1.6 [1.3, 2.0] vs 1.7 [1.2, 2.2], P = .04). During a median follow-up time of 17 [8,28] months, the rate of MACE was 12% (51 events) and was higher in the low-to-low and low-to-high categories in multivariable analysis. The model including serial MFR and perfusion performed better than the baseline model including traditional clinical risk factors in terms of the likelihood ratio and C-statistic (from .74 to .80, P = .04). CONCLUSIONS: In conclusion, our findings suggest that the serial assessment of MFR and perfusion may improve risk stratification beyond traditional clinical risk factors.
引用
- Nikolakopoulos I, Csecs I, Liu YH, et al. Temporal changes in PET myocardial flow reserve: Implications for cardiovascular outcomes. J Nucl Cardiol. 2025. PMID: 40139484. doi:10.1016/j.nuclcard.2025.102194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。